Incidence, risk factors, and epidemiological trends of tracheal cancer: a global analysis
- PMID: 39696563
- PMCID: PMC11654256
- DOI: 10.1186/s12943-024-02188-4
Incidence, risk factors, and epidemiological trends of tracheal cancer: a global analysis
Abstract
Background: Tracheal cancer is a rare malignancy with limited research but high mortality rates. This study aims to analyse recent data to understand the global burden, trends, and risk factors for tracheal cancer, facilitating improved prevention and treatment strategies.
Methods: We conducted a study on tracheal cancer using data from the Global Cancer Observatory and the Cancer Incidence in Five Continents databases. We collected information on the incidence of tracheal cancer, risk factors, and the Human Development Index (HDI) at the country level. The univariate linear regression was used to explore the relationship between tracheal cancer and the various risk factors. We utilised joinpoint regression analysis to calculate the Average Annual Percentage Change (AAPC) in tracheal cancer incidence.
Results: The global age-standardised rate of incidence of tracheal cancer was 2.9 per 10 million (3,472 cases in total) in 2022, with the highest regional incidence observed in Central and Eastern Europe (ASR = 9.0) and the highest national incidence in Hungary (12.5). Higher incidence was found among the males (3.8) than females (2.0); among the older adults aged 50-74 (11.9) than the younger population aged 15-49 (1.2). A higher tracheal cancer incidence ratio was associated with higher levels of smoking, alcohol drinking, diabetes, lipid disorders, and HDI. Despite the overall decreasing trends for all population groups (highest decrease in Thailand; AAPC: -15.06, 95% CI: -21.76 to -7.78, p = 0.002), there was an increase in some female populations (highest increase in Colombia, AAPC: 19.28, 95% CI: 16.48 to 22.15, p < 0.001) and younger populations (highest increase in Ireland; AAPC: 29.84, 95% CI: 25.74 to 34.06, p < 0.001).
Conclusion: This study provides a comprehensive analysis of tracheal cancer, focusing on risk factors and population-level trends. There has been an overall decreasing trend in the incidence of tracheal cancer, particularly among males and older adults, while the decline is less pronounced in females and younger individuals. Further research is needed to explore the underlying drivers of these epidemiological trends.
Keywords: Cancer registry; Epidemiology; Risk factor; Tracheal cancer.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Survey and Behavioural Research Ethics Committee, The Chinese University of Hong Kong (No. SBRE-20–332). Competing interests: The authors declare no competing interests.
Figures






Similar articles
-
Distributions and trends in the global burden of young-onset tracheal, bronchus, and lung cancer by region, age, and sex from 1990 to 2021: An age-period-cohort analysis.Cancer Epidemiol. 2025 Feb;94:102734. doi: 10.1016/j.canep.2024.102734. Epub 2024 Dec 30. Cancer Epidemiol. 2025. PMID: 39740272
-
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends.Lancet Haematol. 2022 Sep;9(9):e670-e677. doi: 10.1016/S2352-3026(22)00165-X. Epub 2022 Jul 14. Lancet Haematol. 2022. PMID: 35843248
-
Global incidence, risk factors, and temporal trends of nasal cancer: A population-based analysis.Cancer Med. 2025 Apr;14(8):e70163. doi: 10.1002/cam4.70163. Cancer Med. 2025. PMID: 40243195 Free PMC article.
-
A novel metric of autoimmune disease burden and its estimated incidence across different stages in life cycle of women.Autoimmun Rev. 2024 Dec;23(12):103671. doi: 10.1016/j.autrev.2024.103671. Epub 2024 Oct 21. Autoimmun Rev. 2024. PMID: 39442592 Review.
-
Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in women of childbearing age from 1990 to 2019.Autoimmun Rev. 2023 Nov;22(11):103450. doi: 10.1016/j.autrev.2023.103450. Epub 2023 Sep 21. Autoimmun Rev. 2023. PMID: 37741529 Review.
Cited by
-
Diagnosis and Treatment of Primary Tracheobronchial Tumors.Cancer Med. 2025 May;14(9):e70893. doi: 10.1002/cam4.70893. Cancer Med. 2025. PMID: 40289301 Free PMC article. Review.
-
Primary malignant tumors of the trachea: a retrospective analysis of the clinical data of 79 patients treated in a single center.Front Oncol. 2025 Apr 9;15:1568589. doi: 10.3389/fonc.2025.1568589. eCollection 2025. Front Oncol. 2025. PMID: 40270602 Free PMC article.
References
-
- Urdaneta AI, Yu JB, Wilson LD. Population Based Cancer Registry Analysis of Primary Tracheal Carcinoma. Am J Clin Oncol. 2011;34(1):32–7. - PubMed
-
- Macchiarini P. Primary tracheal tumours. Lancet Oncol. 2006;7(1):83–91. - PubMed
-
- Licht PB, Friis S, Pettersson G. Tracheal cancer in Denmark: a nationwide study. Eur J Cardiothorac Surg. 2001;19(3):339–45. - PubMed
-
- Siesling S, Zwan JMvd, Izarzugaza I, et al. Rare thoracic cancers, including peritoneum mesothelioma. Eur J Can. 2012;48(7):949–60. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical